Companies: 10,795·Total market cap: $144.5T
OKYO Pharma Limited

OKYO Pharma Limited

EMMLFOTCHealthcare
$0.01
+$0.00(+0.00%)
Market Cap$22725423
P/E Ratio
52W High$0.890499
52W Low$0.0137
Overview

OKYO Pharma Limited (EMMLF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · EMMLF · as of Jun 8, 2026

Key Statistics

EPS (TTM)emmlf eps ttm · emmlf earnings per shareEarnings history
PE Ratio (TTM)emmlf pe ratio ttm · emmlf price to earningsPE Ratio deep dive
Revenue (TTM)emmlf revenue ttm · emmlf annual revenueFull revenue history
Dividend YieldNo Dividenddoes emmlf pay dividends · emmlf dividend yieldDividend history
Shares Outstandingemmlf shares outstanding · emmlf floatShares outstanding history
Next EarningsTBAemmlf earnings date · emmlf next earningsEarnings history

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y-71.69%
5Y-71.69%

About OKYO Pharma Limited

CEOGary S. Jacob
IPO DateOct 9, 2020
Employees7
CountryGB

OKYO Pharma Limited a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead p…

what is okyo pharma limited · emmlf stock overview · okyo pharma limited company profile · who is okyo pharma limited ceo · emmlf OTC · okyo pharma limited headquarters · okyo pharma limited business segments

About Stock Overview & Key Data

OKYO Pharma Limited (EMMLF) is a Healthcare company in the Biotechnology industry, listed on OTC since Oct 9, 2020. As of the latest trading session, EMMLF stock price is $0.01, with a market capitalization of $22.7M. The stock has returned -71.69% over the past 12 months and +0.00% year-to-date.

Frequently Asked Questions

As of the latest trading session, OKYO Pharma Limited (EMMLF) stock price is $0.01. The stock is traded on OTC under the ticker symbol EMMLF. The 52-week range is $0.01 – $0.89.

EMMLF stock priceEMMLF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice